These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 12858071

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparative aspects of triptans in treating migraine.
    Adelman JU, Lewit EJ.
    Clin Cornerstone; 2001; 4(3):53-64. PubMed ID: 12739316
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Botulinum toxin and other new approaches to migraine therapy.
    Ashkenazi A, Silberstein SD.
    Annu Rev Med; 2004; 55():505-18. PubMed ID: 14746533
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Current and emerging second-generation triptans in acute migraine therapy: a comparative review.
    Deleu D, Hanssens Y.
    J Clin Pharmacol; 2000 Jul; 40(7):687-700. PubMed ID: 10883409
    [Abstract] [Full Text] [Related]

  • 8. The long-term tolerability and efficacy of oral zolmitriptan (Zomig, 311C90) in the acute treatment of migraine. An international study. The International 311C90 Long-term Study Group.
    Headache; 1998 Mar; 38(3):173-83. PubMed ID: 9563207
    [Abstract] [Full Text] [Related]

  • 9. The Migraine Intervention Score - a tool to improve efficacy of triptans in acute migraine therapy: the ALADIN study.
    Göbel H, Heinze A.
    Int J Clin Pract; 2011 Aug; 65(8):879-86. PubMed ID: 21762313
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacokinetic evaluation of frovatriptan.
    Negro A, Lionetto L, Casolla B, Lala N, Simmaco M, Martelletti P.
    Expert Opin Drug Metab Toxicol; 2011 Nov; 7(11):1449-58. PubMed ID: 21929465
    [Abstract] [Full Text] [Related]

  • 13. Pharmacology and efficacy of eletriptan for the treatment of migraine attacks.
    Diener HC, McHarg A.
    Int J Clin Pract; 2000 Dec; 54(10):670-4. PubMed ID: 11221281
    [Abstract] [Full Text] [Related]

  • 14. Zolmitriptan 5 mg nasal spray: efficacy and onset of action in the acute treatment of migraine--results from phase 1 of the REALIZE Study.
    Gawel M, Aschoff J, May A, Charlesworth BR, REALIZE Study Team.
    Headache; 2005 Jan; 45(1):7-16. PubMed ID: 15663607
    [Abstract] [Full Text] [Related]

  • 15. Clinical pharmacology of the serotonin receptor agonist, zolmitriptan.
    Peterlin BL, Rapoport AM.
    Expert Opin Drug Metab Toxicol; 2007 Dec; 3(6):899-911. PubMed ID: 18028032
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
    MacGregor EA, Brandes JL, Silberstein S, Jeka S, Czapinski P, Shaw B, Pawsey S.
    Headache; 2009 Oct; 49(9):1298-314. PubMed ID: 19788471
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis.
    Seeburger JL, Cady RK, Winner P, MacGregor A, Valade D, Ge Y, Zhang Y, Hustad CM, Strickler N, Schaefer E, Connor KM, Ho TW.
    Headache; 2012 Jan; 52(1):57-67. PubMed ID: 22078129
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.